✦ LIBER ✦

Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma

✍ Scribed by K. A. Jeglum; K. M. Young; K. Barnsley; A. Whereat

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 639 KB
Volume: 61
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880515)61:10<2042::aid-cncr2820611019>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab in combination with chemothera

Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies

✍ Jorge J. Castillo; Ignacio A. Echenique 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

VAB-5 combination chemotherapy in progno

VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors

✍ Davor Vugrin; Willet F. Whitmore; Robert B. Golbey 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab

Correlation of serum tumor markers in ad

Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery

✍ Davor Vugrin; Alan Friedman; Willet F. Whitmore Jr 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Remission rates induced by chemotherapy alone or by combined chemotherapy and surgery were analyzed in relation to specific serum tumor marker abnormalities immediately before treatment in 103 patients with Stage I11 or bulky Stage I1 nonseminomatous germ cell tumors. Complete remission occurred in

Supportive care versus supportive care a

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

✍ Patricia A. Ganz; Robert A. Figlin; Charles M. Haskell; Nancy la Soto; Jessie Si 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 775 KB

Chemotherapy with rituximab followed by

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

✍ Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high‐dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre

High-dose chemotherapy with hematopoieti

High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience

✍ A. Fléchon; P. Biron; J.P. Droz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C